• Home
  •  / Livzon Pharmaceutical Group

Livzon Pharmaceutical Group

  • Revenue¥10.3 BFY, 2020
  • Market Capitalization¥27 B2022-05-13

OverviewSuggest Edit

Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. It specializes in gastrointestinal drugs, reproductive health, antibiotics, neurogeneration, psychotropic drugs, traditional Chinese medicine, immunomodulators, cardiovascular and cerebrovascular diseases drugs, anti-allergic drugs.

TypePublic
Founded1985
HQZhuhai, CNMap
Websitelivzon.com.cn
View Jobs

Locations

Livzon Pharmaceutical Group is headquartered in
Zhuhai, China

Location Map
All Locations (7)

Latest Updates

Employees (est.) (Dec 2020)8,367(-7%)
Revenue (FY, 2020)¥10.3 B(+13%)
Share Price (May 2022)¥33.6
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Livzon Pharmaceutical Group

Zhu Baoguo

Zhu Baoguo

Chairman

Livzon Pharmaceutical Group Office Locations

Livzon Pharmaceutical Group has offices in Zhuhai, Chengdu, Qingyuan, Shanghai and in 2 other locations
Zhuhai, CN (HQ)
38 Chuangye North Road, Jinwan District
Chengdu, CN
82 Longxing N St, Pengzhou Shi
Qingyuan, CN
Renmin 1st Rd, Qingcheng Qu
Shanghai, CN
No. 1150 Guiqiao Road, Jinqiao Import And Export Processing Zone, Pudong New Area
Shaoguan, CN
89 Gongye W Rd, Wujiang Qu
Shenzhen, CN
Health Yuan Building, No. 17 - 2, Langshan Road, North District, Science And Technology Park
Show all (7)

Livzon Pharmaceutical Group Financials and Metrics

Livzon Pharmaceutical Group Revenue

Livzon Pharmaceutical Group's revenue was reported to be ¥10.34 b in FY, 2020
CNY

Revenue (Q3, 2021)

3.1b

Gross profit (Q3, 2021)

2.0b

Net income (Q3, 2021)

432.7m

EBITDA (Q3, 2021)

245.0m

EBIT (Q3, 2021)

464.3m

Market capitalization (13-May-2022)

27.0b

Closing stock price (13-May-2022)

33.6

Cash (30-Sept-2021)

9.0b

EV

21.6b
Livzon Pharmaceutical Group's current market capitalization is ¥27 b.
Annual
CNYFY, 2018FY, 2019FY, 2020

Revenue

8.7b9.2b10.3b

Cost of goods sold

(3.4b)(3.4b)(3.7b)

Gross profit

5.4b5.9b6.7b

R&D expense

(549.0m)(732.9m)(884.1m)
Quarterly
CNYQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Revenue

2.6b2.3b2.4b2.5b2.5b2.8b3.3b2.8b3.1b

Cost of goods sold

(912.8m)(821.8m)(840.6m)(880.1m)(853.7m)(949.4m)(1.1b)(1.0b)(1.1b)

Gross profit

1.7b1.5b1.5b1.6b1.7b1.8b2.2b1.9b2.0b

R&D expense

(138.6m)(149.9m)(193.6m)(133.9m)(172.5m)(277.8m)(231.5m)(275.4m)(279.4m)
show all
Annual
CNYFY, 2018FY, 2019FY, 2020

Cash

8.6b8.9b10.0b

Accounts Receivable

1.4b1.5b1.7b

Prepaid Expenses

169.8m188.8m150.9m

Inventories

1.1b1.2b1.5b
Quarterly
CNYQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Cash

7.3b7.8b7.2b8.0b7.3b9.0b10.2b8.6b9.0b

Accounts Receivable

1.7b1.8b1.8b1.6b1.7b2.0b1.9b2.2b2.3b

Prepaid Expenses

176.7m186.1m185.0m202.1m188.3m204.6m212.0m353.4m384.5m

Inventories

1.0b1.0b1.1b1.3b1.4b1.4b1.4b1.5b1.5b
show all
Annual
CNYFY, 2018FY, 2019FY, 2020

Net Income

1.2b1.5b2.1b

Depreciation and Amortization

364.1m384.6m394.3m

Inventories

(97.1m)(108.3m)(400.3m)

Accounts Payable

(427.3m)13.3m525.1m
Quarterly
CNYQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Net Income

834.5m1.3b1.2b

Depreciation and Amortization

182.4m194.0m210.5m

Inventories

67.8m(278.9m)(2.2m)

Accounts Payable

134.3m21.5m48.8m
show all
CNYFY, 2018

Revenue/Employee

1.1m
Show all financial metrics

Livzon Pharmaceutical Group Revenue Breakdown

Embed Graph

Livzon Pharmaceutical Group revenue breakdown by business segment: 11.5% from PHARMACEUTICAL OTHER PRESCRIPT, 23.3% from PHARMACEUTICAL DIVERSIFIED, 13.2% from MEDICAL INSTRUMENTS & MACHINES, 51.6% from CHEMICALS and 0.3% from Other

Livzon Pharmaceutical Group Cybersecurity Score

Cybersecurity ratingPremium dataset

B

88/100

Learn more about our premium products
SecurityScorecard logo

Livzon Pharmaceutical Group Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

Learn more about our premium products
CSRHub logo

Livzon Pharmaceutical Group Online and Social Media Presence

Livzon Pharmaceutical Group's Trends

Embed Graph

 Livzon Pharmaceutical Group Frequently Asked Questions

  • When was Livzon Pharmaceutical Group founded?

    Livzon Pharmaceutical Group was founded in 1985.

  • Who are Livzon Pharmaceutical Group key executives?

    Livzon Pharmaceutical Group's key executives are Zhu Baoguo.

  • How many employees does Livzon Pharmaceutical Group have?

    Livzon Pharmaceutical Group has 8,367 employees.

  • What is Livzon Pharmaceutical Group revenue?

    Latest Livzon Pharmaceutical Group annual revenue is ¥10.3 b.

  • What is Livzon Pharmaceutical Group revenue per employee?

    Latest Livzon Pharmaceutical Group revenue per employee is ¥1.2 m.

  • Who are Livzon Pharmaceutical Group competitors?

    Competitors of Livzon Pharmaceutical Group include Jiangsu Nhwa Pharmaceutical, Luye Pharma and NEPG.

  • Where is Livzon Pharmaceutical Group headquarters?

    Livzon Pharmaceutical Group headquarters is located at 38 Chuangye North Road, Jinwan District, Zhuhai.

  • Where are Livzon Pharmaceutical Group offices?

    Livzon Pharmaceutical Group has offices in Zhuhai, Chengdu, Qingyuan, Shanghai and in 2 other locations.

  • How many offices does Livzon Pharmaceutical Group have?

    Livzon Pharmaceutical Group has 7 offices.